Please ensure Javascript is enabled for purposes of website accessibility
Major COVID-19 Vaccine Study Paused After Illness
gvw_ap_news
By Associated Press
Published 4 years ago on
September 8, 2020

Share

Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates if a report of a patient with a serious side effect is linked to the shot.

In a statement issued Tuesday evening, the company said its “standard review process triggered a pause to vaccination to allow review of safety data.”

AstraZeneca didn’t reveal any information about the possible side effect except to call it “a potentially unexplained illness.” The news site STAT first reported the pause in testing, saying the possible side effect occurred in the United Kingdom.

Vaccine Trial Expected to Involve 30,000 People

An AstraZeneca spokesperson confirmed the pause in vaccinations covers studies in the U.S. and other countries. Late last month, AstraZeneca began recruiting 30,000 people in the U.S. for its largest study of the vaccine. It also is testing the vaccine, developed by Oxford University, in thousands of people in Britain, and in smaller studies in Brazil and South Africa.

Two other vaccines are in huge, final-stage tests in the United States, one made by Moderna Inc. and the other by Pfizer and Germany’s BioNTech. Those two vaccines work differently than AstraZeneca’s, and the studies already have recruited about two-thirds of the needed volunteers.

Temporary holds of large medical studies aren’t unusual, and investigating any serious or unexpected reaction is a mandatory part of safety testing. AstraZeneca pointed out that it’s possible the problem could be a coincidence; illnesses of all sorts could arise in studies of thousands of people.

“We are working to expedite the review of the single event to minimize any potential impact on the trial timeline,” the company statement said.

Drugmakers Issue Unusual Safety Pledge

The development came the same day that AstraZeneca and eight other drugmakers issued an unusual pledge, vowing to uphold the highest ethical and scientific standards in developing their vaccines.

The announcement follows worries that President Donald Trump will pressure the U.S. Food and Drug Administration to approve a vaccine before it’s proven to be safe and effective.

The U.S. has invested billions of dollars in efforts to quickly develop multiple vaccines against COVID-19. But public fears that a vaccine is unsafe or ineffective could be disastrous, derailing the effort to vaccinate millions of Americans.

Representatives for the FDA did not immediately respond to requests for comment Tuesday evening.

DON'T MISS

City of Fresno Buys Half of Eldorado Park in Strategic Maxwell-Led Move

DON'T MISS

GOP Picks up Key House Seats While Democrats Say They Still Have a Path to a Majority

DON'T MISS

Costa Expands Lead Over Maher, Richardson Holds Narrow Edge on Bonakdar

DON'T MISS

Clovis’ Measure A and Sanger’s Measure M Get Good News with Thursday Vote Update

DON'T MISS

President-Elect Trump Has Sweeping Plans. Here’s What He’s Proposed.

DON'T MISS

New Look Basketball Bulldogs Open at Home. How Will They Fare Under Walberg?

DON'T MISS

Americans Seek Fresh Start Abroad as Election Sparks Expat Interest

DON'T MISS

President-Elect Trump Names Susie Wiles as Chief of Staff

DON'T MISS

Robert F. Kennedy Jr., Foe of Drugmakers and Regulators, Is Poised to Wield New Power

DON'T MISS

California Beat Trump in Court His First Term. It’s Preparing New Cases for His Second.

UP NEXT

Large Airstrikes Hit Beirut Suburbs as Israel Expands Northern Gaza Operations

UP NEXT

Putin Congratulates Trump on His Election Victory in His First Public Comments on the US Vote

UP NEXT

8-Hour Russian Drone Barrage Keeps Kyiv on Edge as War in Ukraine Nears 1,000 Days

UP NEXT

Cuba Left Reeling After Category 3 Hurricane Ravages Island and Knocks Out Power Grid

UP NEXT

Trump Promises to Bring Lasting Peace to a Tumultuous Middle East. But Fixing It Won’t Be Easy

UP NEXT

Lebanon Files Complaint Against Israel at UN Labor Body Over Deadly Pager Explosions

UP NEXT

Despite Trump’s Unpredictability, Netanyahu Sees a More Favorable US President

UP NEXT

Israeli Strikes Target Syria for a Second Day in a Row

UP NEXT

Israel’s Netanyahu Dismisses Defense Minister in Surprise Announcement

UP NEXT

Palestinians in Gaza Fear Neither Candidate in US Election Will Help Them

Clovis’ Measure A and Sanger’s Measure M Get Good News with Thursday Vote Update

4 hours ago

President-Elect Trump Has Sweeping Plans. Here’s What He’s Proposed.

5 hours ago

New Look Basketball Bulldogs Open at Home. How Will They Fare Under Walberg?

5 hours ago

Americans Seek Fresh Start Abroad as Election Sparks Expat Interest

5 hours ago

President-Elect Trump Names Susie Wiles as Chief of Staff

6 hours ago

Robert F. Kennedy Jr., Foe of Drugmakers and Regulators, Is Poised to Wield New Power

7 hours ago

California Beat Trump in Court His First Term. It’s Preparing New Cases for His Second.

7 hours ago

With Mountain West Title Out of Reach, What Is Fresno State Playing For?

8 hours ago

Former Fresno State Bull Rider, a Vietnam Vet, Calls Central Valley Honor Flight ‘Life-Changing’

8 hours ago

Don’t Expect Kamala Harris’ Loss to Boost Gavin Newsom’s Presidential Prospects

8 hours ago

City of Fresno Buys Half of Eldorado Park in Strategic Maxwell-Led Move

The city of Fresno now owns a new park. Or at least half of it. Technically, the city of Fresno did not own El Dorado Park, at Barstow Avenu...

3 hours ago

3 hours ago

City of Fresno Buys Half of Eldorado Park in Strategic Maxwell-Led Move

The U.S. Capitol is seen from Pennsylvania Avenue in Washington, on Election Day, Tuesday, Nov. 5, 2024. (AP Photo/Jon Elswick)
4 hours ago

GOP Picks up Key House Seats While Democrats Say They Still Have a Path to a Majority

4 hours ago

Costa Expands Lead Over Maher, Richardson Holds Narrow Edge on Bonakdar

4 hours ago

Clovis’ Measure A and Sanger’s Measure M Get Good News with Thursday Vote Update

5 hours ago

President-Elect Trump Has Sweeping Plans. Here’s What He’s Proposed.

5 hours ago

New Look Basketball Bulldogs Open at Home. How Will They Fare Under Walberg?

5 hours ago

Americans Seek Fresh Start Abroad as Election Sparks Expat Interest

Trump co-campaign manager Susie Wiles is seen at Nashville International Airport as Republican presidential candidate former President Donald Trump arrives, July 27, 2024, in Nashville, Tenn. (AP File)
6 hours ago

President-Elect Trump Names Susie Wiles as Chief of Staff

Search

Send this to a friend